People: Physicist Returns To Israel To Oversee New Submicron Institute At Weizmann

After spending 17 years in the United States, Israeli-born physicist Mordehai Heiblum has returned to his native country to head the Joseph H. and Belle R. Braun Center for Submicron Research at the Weizmann Institute of Science in Rehovot. Since 1978, Heiblum has worked at the IBM Thomas J. Watson Research Center in Yorktown Heights, N.Y., where he most recently was the manager and a research staff member of IBM's microstructure physics group. His present interests include ballistic electrons

Written byKen Kalfus
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

After spending 17 years in the United States, Israeli-born physicist Mordehai Heiblum has returned to his native country to head the Joseph H. and Belle R. Braun Center for Submicron Research at the Weizmann Institute of Science in Rehovot. Since 1978, Heiblum has worked at the IBM Thomas J. Watson Research Center in Yorktown Heights, N.Y., where he most recently was the manager and a research staff member of IBM's microstructure physics group. His present interests include ballistic electrons in semiconductors and molecular beam epitaxy (MBE).

At Weizmann, Heiblum will supervise the construction of a research complex that will combine MBE with advanced optical and electron-beam techniques to study new materials and submicron structures. The study of minute semiconductor devices could lead to the discovery of new physical phenomena, as well as the development of components faster and smaller than those operating today.

Heiblum expects that it will take him ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies